Retrophin

Employees:
140
Market Cap:
$719.19 million
Revenue:
$134.11 million
Net Income:
$-55.33 million
NASDAQ:
RTRX

Martin Shkreli (/'skr?li/, born 1983) is an American entrepreneur and pharmaceutical executive. He is co-founder of the hedge fund MSMB Capital Management, co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin, and founder and former CEO of Turing Pharmaceuticals. Wikipedia

Retrophin
Employees:
140
Market Cap:
$719.19 million
Revenue:
$134.11 million
Net Income:
$-55.33 million
NASDAQ:
RTRX

Martin Shkreli (/'skr?li/, born 1983) is an American entrepreneur and pharmaceutical executive. He is co-founder of the hedge fund MSMB Capital Management, co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin, and founder and former CEO of Turing Pharmaceuticals. Wikipedia

Jul 22, 4:51 PM

We were honored to attend the GFPD conference this past weekend #GFPD2015Omaha #raredisease @GlobalFoundPD

May 26, 2:42 PM

Retrophin supports Dean Greg Crawford as he bikes 3,500 miles for #raredisease research beginning May 27 #RoadtoDiscovery http://ow.ly/NrtiS

7 jobs at Retrophin

Jobs in